Publikationen in Zusammenarbeit mit Forschern von Centro Nacional de Microbiología (51)

2024

  1. Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803

  2. Characterizing carbapenemase-producing Escherichia coli isolates from Spain: high genetic heterogeneity and wide geographical spread

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  3. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

    mSphere, Vol. 9, Núm. 3

  4. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

  5. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

  6. Invasive disease caused simultaneously by two different serotypes of Streptococcus pneumoniae: a microbiological appreciation

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 5, pp. 1013-1016

2023

  1. An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004–2020)

    Frontiers in Microbiology, Vol. 14

  2. Carbapenemase-Producing Klebsiella pneumoniae in COVID-19 Intensive Care Patients: Identification of IncL-VIM-1 Plasmid in Previously Non-Predominant Sequence Types

    Antibiotics, Vol. 12, Núm. 1

  3. Corrigendum: Phenotypic and molecular characterization of IMP-producing Enterobacterales in Spain: predominance of IMP-8 in Klebsiella pneumoniae and IMP-22 in Enterobacter roggenkampii (Frontiers in Microbiology, (2022), 13, (1000787), 10.3389/fmicb.2022.1000787)

    Frontiers in Microbiology

2022

  1. Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 9, pp. 2389-2398

  2. Phenotypic and molecular characterization of IMP-producing Enterobacterales in Spain: Predominance of IMP-8 in Klebsiella pneumoniae and IMP-22 in Enterobacter roggenkampii

    Frontiers in Microbiology, Vol. 13

2020

  1. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2

    International Journal of Antimicrobial Agents, Vol. 56, Núm. 1

  2. Direct identification of pneumococcal serotypes in blood cultures by a PCR-reverse-hybridisation technique

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 170-173

  3. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 6, pp. 753-759

  4. Interregional spread in Spain of linezolid-resistant Enterococcus spp. isolates carrying the optrA and poxtA genes

    International Journal of Antimicrobial Agents, Vol. 55, Núm. 6

  5. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2018

  1. Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study

    Vaccine, Vol. 36, Núm. 52, pp. 7993-8000

2017

  1. Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3283-3287

  2. The carbapenemase-producing Klebsiella pneumoniae population is distinct and more clonal than the carbapenem-susceptible population

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4

2016

  1. Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 8, pp. 2131-2138